Details surrounding the management of inspections from announcement to close out meeting
The steps necessary to prepare for an FDA inspection
The methodology for responding to 483 and warning letters
Responses to FAQs regarding typical inspector requests during inspections
Common pitfalls to avoid during an inspection
Templates for response letters
Who should Attend
Attendees from biopharmaceutical, pharmaceutical, medical device and biologics companies, including:
Regulators
Internal Auditors
Compliance Officers
Legal Departments
QC Managers
Validation Managers
Facilities and Engineering Department Staff
QA Managers
Senior Management
Compliance Consultants
Past Events
Managing FDA Inspections from Readiness through Follow Up Responses 2016 - 26-27 Jan 2016, Renaissance Orlando Airport Hotel, Florida, United States (48768)
Managing FDA Inspections from Readiness through Follow Up Responses 2026
Important
Please, check "Managing FDA Inspections from Readiness through Follow Up Responses" official website for possible changes, before making any traveling arrangements
